Eyers, FionaStambas, JohnBoyle, David BRamshaw, IanRamsay, Alistair JRanasinghe, Charani2015-12-100264-410Xhttp://hdl.handle.net/1885/50660In this study we have firstly compared a range of recombinant DNA poxvirus prime-boost immunisation strategies and shown that combined intramuscular (i.m.) 2× DNA-HIV/intranasal (i.n.) 2× FPV-HIV prime-boost immunisation can generate high-level of HIV-sKeywords: DNA vaccine; Fowlpox virus vector; Gag protein; Human immunodeficiency virus 1 vector; immunoglobulin A; immunoglobulin G; immunoglobulin G1; immunoglobulin G2a; lipofectamine; plasmid DNA; recombinant DNA; unclassified drug; vaccinia virus vector; virus DNA vaccines; Mucosal immunity; Poxvirus vectors; T cell avidityA comparative analysis of HIV-specific mucosal/systemic T cell immunity and avidity following rDNA/rFPV and poxvirus-poxvirus prime boost immunisations201110.1016/j.vaccine.2011.01.1062016-02-24